8i Acquisition 2 Corp

EUDA Health Holdings Ltd. engages in the provision of a digital healthcare analytic platform. Its ecosystem-based approach serves a full spectrum of healthcare needs, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and after care services. The company is headquartered in Singapore.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

EUDA Health Holdings Ltd. engages in the provision of a digital healthcare analytic platform. It operates through Medical Services and Property Management Services segments. The Medical Services segment involves in the healthcare specialty group business offering range of specialty care services to patients, and engaged in the medical facility general practice clinic that provides holistic care for various illnesses. The Property Management Services segment operates in the property management that services shopping malls, business office building, and residential apartments. The company was founded by Kelvin Chen on 2019 is headquartered in Singapore.

Singapore, May 31, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the SPA (the “SPA Amendment”) to extend the time for LAX to complete its financial, operational and legal due diligence review of EUDA Health from May 31, 2022 to June 15, 2022.

8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period

Singapore, Dec. 13, 2021 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ: LAXXU) (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company and led by Chief Executive Officer, Meng Dong (James) Tan, today announced that commencing December 14, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's ordinary shares, warrants and rights included in the units. No fractional rights or warrants will be issued upon separation of the units and only whole rights and warrants will trade. The ordinary shares, warrants and rights that are separated will trade on The Nasdaq Global Market (“NASDAQ”) under the symbols “LAX,” “LAXXW,” and “LAXXR,”. Those units not separated will continue to trade on NASDAQ under the symbol "LAXXU." Holders of units will need to have their brokers contact American Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into ordinary shares, warrants and rights. The units began trading on NASDAQ under the ticker symbol “LAXXU” on November 22, 2021. The offering was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, or by accessing the SEC's website, www.sec.gov .

8i Acquisition 2 Corp. Announces the Separate Trading of its Ordinary Shares, Warrants and Rights, Commencing December 14, 2021

Aeroclean Technologies

Applied Blockchain Inc

Legato Merger Corp II

Mana Capital Acquisition Corp

The IPO market got a break during the shortened holiday week, with just one IPO and six SPACs. Air purification company AeroClean Technologies priced its Reg A+ IPO at the low end to raise $25 million at a $139 million market cap.

U.S. IPO Weekly Recap: The Shortened Holiday Week Brings Just 1 IPO

Singapore, Nov. 24, 2021 (GLOBE NEWSWIRE) --  8i Acquisition 2 Corp. (NASDAQ: LAXXU) (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company and led by Chief Executive Officer, Meng Dong (James) Tan, today announced that it closed its initial public offering of 8,625,000 units at an offering price of $10.00 per unit, which includes 1,125,000 units issued pursuant to the full exercise of the underwriter's over-allotment option, for aggregate gross proceeds to the Company of $86,250,000. The units began trading on the NASDAQ Global Market (“NASDAQ”) under the ticker symbol “LAXXU” on November 22, 2021. Each unit consists of one ordinary share, one warrant to purchase one-half (1/2) of one ordinary share, and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of the Company's initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares, warrants and rights are expected to be listed on NASDAQ under the symbols “LAX,” “LAXXW,” and “LAXXR,” respectively.

8i Acquisition 2 Corp. Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Over-Allotment Option

News for 8i Acquisition 2 Corp Stock (LAXXU)